Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis
NCT00541827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2013-09-27
Summary
The primary aim of the study is to demonstrate that mitochondrial dysfunction occurs in both skeletal muscle and circulating platelets of severely septic and septic shock ICU-admitted patients. Secondary aims are to clarify the pathogenesis and the clinical relevance of mitochondrial damage during sepsis.
Conditions
- Severe Sepsis
- Septic Shock
Sponsors & Collaborators
-
European Society of Intensive Care Medicine
collaborator OTHER -
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
lead OTHER
Principal Investigators
-
Luciano Gattinoni, MD · Ospedale Maggiore Policlinico Mangiagalli e Regina Elena
-
Alessandro Protti, MD · Ospedale Maggiore Policlinico Mangiagalli e Regina Elena
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2011-08-31
- Completion
- 2012-08-31
Countries
- Italy
Study Locations
More Related Trials
-
Metabolic Cluster Analysis in Septic Shock Patients
NCT06500156 ·Status: RECRUITING
-
Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical Relevance
NCT02391792 ·Status: UNKNOWN
-
Monitoring Mitophagy In Myeloid Cells Upon Intensive Care
NCT05040503 ·Status: COMPLETED ·Phase: NA
-
Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study
NCT04288635 ·Status: RECRUITING
-
Muscle Atrophy in Sepsis
NCT00583206 ·Status: WITHDRAWN
-
Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients
NCT06010186 ·Status: RECRUITING ·Phase: NA
-
Effect of Lipopolysaccharide on Skeletal Muscle Functions
NCT01423968 ·Status: COMPLETED ·Phase: NA
-
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis
NCT05110937 ·Status: RECRUITING
-
Temporal Changes of Lactate in CLASSIC Patients
NCT05629780 ·Status: COMPLETED ·Phase: NA
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED
-
Myeloid-derived Suppressor Cells in Sepsis
NCT03540797 ·Status: UNKNOWN
-
Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.
NCT01411670 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684 ·Status: RECRUITING
-
The Effect of Esmolol on Clinical Prognosis of Patients With Severe Sepsis
NCT02794025 ·Status: COMPLETED ·Phase: NA
-
Mitochondrial DNA as a Biomarker of Sepsis Severity
NCT03077672 ·Status: COMPLETED
-
Lotta Alla Sepsi Ospedaliera - Fighting Hospital Sepsis
NCT01804764 ·Status: COMPLETED
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Sensitivity and Specificity of Leucocytes Profiling Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Observational Clinical Trial
NCT06612307 ·Status: COMPLETED
-
Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock
NCT00159952 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Monitoring Resuscitation in Severe Sepsis and Septic Shock
NCT01747057 ·Status: UNKNOWN ·Phase: NA
-
Zinc and Inflammation in Sepsis
NCT01328509 ·Status: COMPLETED
-
The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock
NCT05402553 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
COMPACT - COMbining Plasma-filtration and Adsorption Clinical Trial
NCT00332371 ·Status: TERMINATED ·Phase: NA
-
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
NCT05094856 ·Status: COMPLETED
-
Ultrasound Diaphragmatic Thickening to Monitor Its Dysfunction in Patients With Sepsis
NCT02474797 ·Status: COMPLETED ·Phase: NA